Close Menu

NEW YORK – The US Department of Health and Human Services said on Wednesday that it has determined that the US Food and Drug Administration will not require premarket review of laboratory-developed tests without notice and comment rulemaking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.